211 related articles for article (PubMed ID: 36613596)
1. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease.
Rabbani N; Adaikalakoteswari A; Larkin JR; Panagiotopoulos S; MacIsaac RJ; Yue DK; Fulcher GR; Roberts MA; Thomas M; Ekinci E; Thornalley PJ
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613596
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products in the pathogenesis of chronic kidney disease.
Rabbani N; Thornalley PJ
Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
[TBL] [Abstract][Full Text] [Related]
3. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG
PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products and arterial stiffness in patients with diabetic nephropathy and patients with chronic kidney disease without diabetes.
Stróżecki P; Kurowski R; Flisiński M; Stefańska A; Odrowąż-Sypniewska G; Manitius J
Pol Arch Med Wewn; 2013; 123(11):609-16. PubMed ID: 24036618
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation endproducts and dicarbonyls in end-stage renal disease: associations with uraemia and courses following renal replacement therapy.
Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Kooman JP; Schalkwijk CG
Clin Kidney J; 2020 Oct; 13(5):855-866. PubMed ID: 33123361
[TBL] [Abstract][Full Text] [Related]
6. Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle.
Masania J; Wijten P; Keipert S; Ost M; Klaus S; Rabbani N; Thornalley PJ
Redox Biol; 2023 Feb; 59():102574. PubMed ID: 36521306
[TBL] [Abstract][Full Text] [Related]
7. Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease.
Hanssen NMJ; Stehouwer CDA; Schalkwijk CG
Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):26-33. PubMed ID: 30320620
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation endproducts in food and their effects on health.
Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
[TBL] [Abstract][Full Text] [Related]
9. Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.
Saulnier PJ; Wheelock KM; Howell S; Weil EJ; Tanamas SK; Knowler WC; Lemley KV; Mauer M; Yee B; Nelson RG; Beisswenger PJ
Diabetes; 2016 Dec; 65(12):3744-3753. PubMed ID: 27609106
[TBL] [Abstract][Full Text] [Related]
10. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.
Ahmed N; Thornalley PJ
Biochem J; 2002 May; 364(Pt 1):15-24. PubMed ID: 11988071
[TBL] [Abstract][Full Text] [Related]
11. Fluorophores advanced glycation end products (AGEs)-to-NADH ratio is predictor for diabetic chronic kidney and cardiovascular disease.
Ciobanu DM; Olar LE; Stefan R; Veresiu IA; Bala CG; Mircea PA; Roman G
J Diabetes Complications; 2015; 29(7):893-7. PubMed ID: 26169772
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.
Perkins BA; Rabbani N; Weston A; Ficociello LH; Adaikalakoteswari A; Niewczas M; Warram J; Krolewski AS; Thornalley P
PLoS One; 2012; 7(4):e35655. PubMed ID: 22558190
[TBL] [Abstract][Full Text] [Related]
13. Serum Levels of Protein-Bound Methylglyoxal-Derived Hydroimidazolone-1 are Independently Correlated with Asymmetric Dimethylarginine.
Tahara N; Kojima R; Yoshida R; Bekki M; Sugiyama Y; Tahara A; Maeda S; Honda A; Igata S; Nakamura T; Sun J; Matsui T; Fukumoto Y; Matsui T; Yamagishi SI
Rejuvenation Res; 2019 Oct; 22(5):431-438. PubMed ID: 30661488
[TBL] [Abstract][Full Text] [Related]
14. Protein glycation - biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine.
Rabbani N; Thornalley PJ
Redox Biol; 2021 Jun; 42():101920. PubMed ID: 33707127
[TBL] [Abstract][Full Text] [Related]
15. Protein Glycation in Plants-An Under-Researched Field with Much Still to Discover.
Rabbani N; Al-Motawa M; Thornalley PJ
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486308
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Chemically Labile Glycation Adducts in Seed Proteins: Case Study of Methylglyoxal-Derived Hydroimidazolone 1 (MG-H1).
Antonova K; Vikhnina M; Soboleva A; Mehmood T; Heymich ML; Leonova T; Bankin M; Lukasheva E; Gensberger-Reigl S; Medvedev S; Smolikova G; Pischetsrieder M; Frolov A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357424
[TBL] [Abstract][Full Text] [Related]
17. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
[TBL] [Abstract][Full Text] [Related]
18. High serum level of methylglyoxal-derived AGE, Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine, independently relates to renal dysfunction.
Ito K; Sakata N; Nagai R; Shirakawa JI; Watanabe M; Mimata A; Abe Y; Yasuno T; Sasatomi Y; Miyake K; Ueki N; Hamauchi A; Nakashima H
Clin Exp Nephrol; 2017 Jun; 21(3):398-406. PubMed ID: 27344336
[TBL] [Abstract][Full Text] [Related]
19. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
[TBL] [Abstract][Full Text] [Related]
20. Circulating Concentrations of advanced Glycation end Products, Carboxymethyl Lysine and Methylglyoxal are Associated With Renal Function in Individuals With Diabetes.
Ding L; Hou Y; Liu J; Wang X; Wang Z; Ding W; Zhao K
J Ren Nutr; 2024 Mar; 34(2):154-160. PubMed ID: 37802233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
